Our collective expertise and insider experience are some of our most powerful and unique assets. IntuitiveX is not simply another incubator.

Together, we have decades of combined experience as an end-to-end resource to other life science innovators, drawing upon our unique personal experiences as inventors and investors.

We are truly hands-on in every step of the process, taking a customized and cross-disciplinary approach for each of our partners. By working together, we exponentially increase the ability for every idea to come to life.

Meet the Founders: Andy, Jeffrey, Mark, Simon and Josh

Your Team of Experts

With our deeply experienced management team and strategic partnerships, we have assembled the intellectual, engineering, regulatory, operational and financial resources needed to take a great idea from concept to commercialization.

Mr. Choi has over 20 years of experience in product development and commercialization with expertise in the medical device industry.  He has held executive positions ranging from engineering to marketing and sales in start-up settings to Fortune 500 companies.

Prior to co-founding Intuitive-X, Mr. Choi was the Chief Business Development Officer at CTL and the VP of R&D at Ellipse Technologies and VertiFlex.  While at VertiFlex, he introduced a pioneering minimally invasive technology, enabling interventional physicians to surgically treat lumbar spinal stenosis. He also led the development and the asset sale of a spinal fusion system to Stryker, achieving a 10x return in less than a year from concept to commercialization.

For almost 10 years, Mr. Choi held leadership positions in both marketing and engineering with Stryker Spine and Orthopedics.  As a Business Director and a Chief Engineer, he led the development and commercialization of numerous flagship products ranging from Minimally Invasive Systems to Surgical Navigation.  Under his leadership, the MIS business unit achieved 70% growth, earning him the Stryker Field Impact award.  In 2007, he was showcased in the Stryker Corporation Annual Report for his contribution in developing and launching the Xia 3 Spinal Fusion System, which achieved $200 million in global sales in the first year.  Mr. Choi is an author of multiple US and international patents.

Mr. Choi earned his B.S. in Mechanical Engineering from U.C. Berkeley and received his MBA from Rutgers University.  He also completed executive education program from the Wharton School of the University of Pennsylvania.


Dr. Roh has over fifteen years of experience as an inventor, angel investor, and serial entrepreneur and holds multiple patents through the USPTO. He is a Co-Founder of Intuitive IP, a Seattle-based intellectual property firm created to help life science entrepreneurs transform their ideas into products and services that scale into businesses, which ultimately help patients lead healthier, more productive lives.

He currently serves as a consultant on Stryker corporation’s Surgical Design and Innovation team and was instrumental in the development of their most commercially successful minimally invasive spine system of all time, ES2, as well as their marquee lateral access platform, ARIA. His experience as a serial entrepreneur includes the successful launch, scalable growth, and ultimate acquisition of Advanced Biologics to Bioventus in 2014.

Dr. Roh currently serves as the Chair of Swedish Hospital’s Integrated Spine Program, is the Chair of the Seattle Science Foundation’s annual Minimally Invasive Spine Symposium, and serves as a consultant on Providence Venture’s Strategy & Innovation team. He serves as the Chair of the Arthritis Foundation’s Executive Leadership Board in Washington state and is an Executive Board Member of ProOrtho, Division of Proliance Surgeons. He is actively involved in key strategic initiatives centered on excellence in clinical care, optimization of patient satisfaction, and value-based healthcare delivery.

He completed his orthopedic surgery residency at Case Western Reserve University and his spine surgery fellowship at Weill Cornell Medicine’s world-renowned Hospital for Special Surgery in NYC. He is a graduate of the Michael G. Foster School of Business MBA program at the University of Washington, serves as a speaker and judge for UW’s Buerk Center for Entrepreneurship, and is as an advisor for CoMotion, the tech transfer office of the UW. He is currently enrolled at Columbia University’s Executive Masters of Science in Technology Management program in NYC.

Mr. Chung is a certified public accountant with almost 20 years of experience in providing the management advisory and attestation services primarily with KPMG to a variety of domestic and international based companies in accordance with PCAOB requirements, U.S. GAAP, Statements on Standards for Accounting and Review Services (SSARS), and International Financial Reporting Standards (IFRS). His professional experience ranges from initial public offerings, mergers, and acquisitions, financial due diligence, SEC registration statements and Sarbanes-Oxley 404 among many others.

He has significant experience in various industries including financial services, consumer market, and industrial products and has served private and public companies ranging from development stage enterprises to Fortune Global 500 companies.

Mr. Chung is also an angel investor and serves as an advisor and a mentor at multiple venture capitals and incubators, where he works closely with investors and entrepreneurs to create a healthy business ecosystem, including education sessions, connecting advisors and introduction to investors, then combining seed capital and hands-on help to positively impact the entrepreneurs and early-stage startups.

Mr. Chung currently serves as a board member of East Los Angeles College Foundation, enthusiastically supporting the role of improving the quality, sustainability and student involvement of the college programs and community.

He is a member of the American Institute of Certified Public Accountants and earned his Master of Business Administration and Bachelor of Science degree in international business from the University of Houston.

Mr. Robinson has extensive IP transactional and monetization experience. Over the past 10 years he has completed over 150 IP transactions ranging from small single asset sales to multi-faceted, complex transactions with hundreds of assets and a transaction value of eight figures. His clients have included individual inventors, universities, privately-held companies and Fortune 500 corporations.

In addition to being an expert in structuring and negotiating patent transactions, Mr. Robinson has spent the past three years generating IP for nascent companies and individual inventors and has helped raise millions of dollars for multiple startups with emerging IP.

Mr. Robinson holds degrees from Kings College, Cambridge and the University of Washington, Seattle.

Mr. Han specializes in intellectual property law with an emphasis on strategic portfolio development, investment due diligence, and commercialization of IP.

Mr. Han previously served as Senior IP Counsel at Intellectual Ventures where his team was responsible for managing all aspects of prosecution and asset maintenance for one of the world’s largest patent portfolios, with more than 30,000 assets and over $6 billion in investor capital.

Before joining Intellectual Ventures, Mr. Han practiced intellectual property law for over 10 years representing clients such as Microsoft, Hewlett Packard, STMicroelectronics, and Seagate.

Mr. Han earned his J.D. from the University of Minnesota Law School. He is a member of the Washington State Bar and is registered to practice before the United States Patent and Trademark Office.

Our Services


  • Patent Landscaping
  • Patent Application Drafting and Prosecution
  • Patent Portfolio Analysis and Management
  • IP Licensing and Transactions


  • Concept Development and Prototyping
  • IP Strategy and Consulting
  • Regulatory (FDA, KFDA & CE) and Quality Systems Management
  • Product Development and Engineering
  • Manufacturing and Marketing for full Commercialization


  • Valuations
  • Company Incorporation
  • Corporate Accounting and Financials
  • Guidance through the FDA regulatory process
  • Access to seed and investment capital

Trusted Collaborators

Accomplishing far more together than we can alone.

Our Portfolio Companies

Our Locations

HQ Seattle: 500 Mercer Street, Seattle, WA 98109
Orange County: 26020 Acero Suite 100 Mission Viejo, CA 92691
Los Angeles: 3470 Wilshire Blvd., Suite 950, Los Angeles, CA 90010
New York City/New Jersey: 2050 Center Ave, Suite 450, Fort Lee, NJ 07024
Seoul: Gangnam-gu, Samsung-ro, 773 4F, Seoul, South Korea
London: 152 City Road London, EC1V, 2NX

Contact Us

To learn more about partnering with our team, book a complimentary session: